← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Pop Biotechnologies, Inc
Buffalo, NY
$8,781,806
Total funding
12
Grants
Funding over time
peak $2.1M · FY2018–25$2.5M$1.9M$1.3M$625K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,781,806 · 12
By mechanism
R42$2,833,334 · 2
R44$1,899,426 · 1
R41$1,720,283 · 4
N43$1,199,703 · 2
R43$879,187 · 2
SB1$249,873 · 1
Investigators at Pop Biotechnologies, Inc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$1,001,404
R42 · FY2022 · CA
Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$998,596
R42 · FY2023 · CA
Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment$950,225
R44 · FY2024 · AI
Advanced testing of a hexavalent adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment$949,201
R44 · FY2025 · AI
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes$833,334
R42 · FY2025 · AG
A Liposomal Platform for Spontaneous, Particleized Presentation of HIV Trimer Immunogens$599,897
N43 · FY2019 · AI
MULTIVALENT QS-18 PROTEIN NANOPARTICLES FOR A BROADLY PROTECTIVE INFLUENZA VIRUS VACCINE$599,806
N43 · FY2023 · AI
Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$399,917
R41 · FY2020 · CA
Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant Candida species$300,000
R41 · FY2025 · AI
Liposome-displayed peptide vaccine against disseminated candidiasis by clinically-relevant Candida species$300,000
R41 · FY2024 · AI
Developing a Thermostable SARS-CoV-2 RBD-particle Vaccine$299,991
R43 · FY2021 · AI
Developing a Thermostable SARS-CoV-2 RBD-particle Vaccine$299,991
R43 · FY2022 · AI
Clinical Translation of Interstitial Chemophototherapy with Light-Activated Nanoparticulate Doxorubicin$249,873
SB1 · FY2024 · CA
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes$248,855
R41 · FY2023 · AG
Mosaic Display of Multivalent Tau and A-Beta peptides on Immunogenic SNAP Liposomes$247,714
R41 · FY2024 · AG
Scalable Formulation and Production of Photosensitive Nanoparticles for Cancer Therapy$224,205
R43 · FY2018 · CA
An adjuvanted influenza vaccine platform for dose sparing, multiplexing, and rapid deployment$223,797
R41 · FY2020 · AI
Scalable Formulation and Production of Photosensitive Nanoparticles for Cancer Therapy$55,000
R43 · FY2019 · CA